Skip to content

Comparison of intrathecal 0.75% ropivacaine heavy against 0.5% bupivacaine heavy in lower abdominal and lower limb surgery

To compare efficacy of intrathecal 0.75% heavy ropivacaine against 0.5% bupivacaine heavy in lower abdominal and lower limb surgeries - RoBu

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040955
Enrollment
50
Registered
2022-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ropivacaine 0.75% Heavy: efficacy of intrathecal 0.75% ropivacaine heavy 3 ml in lower abdominal and lower limb surgery Control Intervention1: Bupivacaine 0.5% Heavy: efficacy of intra

Sponsors

Dr Harshad Mahajan
Lead Sponsor
Dr Sandipbhai J Patel
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All patients undergoing elective lower limb orthopedic and lower abdominal surgery under spinal anaesthesia having ASA status I & II, between age group of 20 to 50 yrs., with weight of 50 to 70 kg & height of 150 ââ?¬â?? 170 cm of either sex.

Exclusion criteria

Exclusion criteria: Patients having contraindications to spinal anaesthesia & known drug allergy

Design outcomes

Primary

MeasureTime frame
Duration of onset of sensory level by pinprick upto L1 & Motor level by bromage scale of 3 of inability to move thigh, knee and ankle will be assessed. Peak sensory level achieved & It�s duration will be assessed.Timepoint: Duration of onset of sensory level by pinprick upto L1 & Motor level by bromage scale of 3 of inability to move thigh, knee and ankle will be assessed every minute till end result. Peak sensory level achieved & It�s duration will be assessed every minute till end result.

Secondary

MeasureTime frame
Intra-opeative haemodyamic parameters (SBP, DBP, SPO2, RR) will be assessed every 5 min for 30 minutes & variation of �± 30% will be marked. Also time of two segment sensory regression will be assessed. Post operatively duration of analegesia with first occurence of sensation of pain will be assessed. Side effects if any will be noticed.Timepoint: Hemodynamic Parameters Every 5 Minute, For 30 Minute. Occurrence of pain sensation every 5 min till pain complaint. Side effects monitored for 24 Hours.

Countries

India

Contacts

Public ContactDr Sandipbhai J Patel

GMC Jalgaon

sandip2027@yahoo.co.in7507271786

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026